With Collective, the useful opening question is not simply “Is it $59 or $69 a month?” It is “What exactly am I buying, from whom, and what happens after the first payment?” Collective advertises compounded semaglutide at $59 monthly and compounded tirzepatide at $69 monthly, plus a $199 annual membership. Those figures describe different purchases: medication on one billing schedule and access to a supporting platform and services on another.
This documentary review examines Collective’s public commercial pages, terms and privacy policy, consulted October 19, 2026. The business identifies itself as Health for Everyone Inc., doing business as CollectiveOS, and describes a platform connecting users with independent medical practices and pharmacies—not a medical practice itself. Its documentation provides useful details about enrollment, messaging and cancellation, but leaves important questions about formulations, dispensing partners and some potential charges unresolved. The aim here is to help prospective patients prepare specific questions, not recommend a treatment.
At a glance
- Advertised medication prices
- Compounded semaglutide is advertised at $59/month and compounded tirzepatide at $69/month, at the same price for any dose, plus a separate $199 annual membership.Sources: [7]
- Who provides care
- CollectiveOS says independent medical practices and providers control clinical care; the platform does not employ or supervise those clinicians.Sources: [6]
- Trial and renewal
- The commercial offer describes 21 days without a membership charge, while medication remains payable. Terms qualify trial eligibility and provide for automatic annual membership renewal.
- Geographic availability
- Collective advertises availability in 44 states, excluding Alabama, California, Louisiana, Massachusetts, Mississippi and Washington.Sources: [7]
Who will actually be responsible for my care?
Collective’s legal identity matters because the visible brand is not the entity making treatment decisions. Its footer lists Health for Everyone Inc. d/b/a CollectiveOS at 1940 Fountain View Dr, PMB 3077, Houston, Texas 77057. The terms describe a membership-based platform facilitating telehealth consultations and prescription wellness products through independent licensed providers and pharmacies. They explicitly say CollectiveOS is not a medical provider or group and does not own, operate, employ or supervise the clinical practices.
The privacy policy names MDIntegrations and its network of independent medical groups as examples of organizations conducting virtual consultations. That reference does not identify the particular practice or clinician who would handle an individual’s case. Before paying, ask for the treating practice’s name, the prescriber’s credentials, and the route for clinical complaints or records requests. Also ask which organization handles an unresolved prescription problem when platform support and the medical practice have different responsibilities.
There is a similar distinction in privacy documentation. The platform policy describes sharing personal information with pharmacy, telehealth, payment, logistics, hosting, analytics and support partners under stated contractual restrictions. Protected health information from consultations and prescription fulfillment is addressed separately through applicable health privacy laws and the provider’s privacy notice. Request that notice rather than assuming the platform policy explains every clinical data use. Our program-fit questions offer a framework for sorting these responsibilities.
What would I pay now, and what could be charged later?
The published offer is unusually specific about its two main charges: $59 per month for compounded semaglutide or $69 per month for compounded tirzepatide, with a separate $199 annual membership. Collective says the medication price is the same at any dose and that multi-month orders are not required. The documentation does not, however, specify the route, presentation or quantity supplied per shipment. A monthly price therefore should not be treated as a complete description of the product being purchased.
The membership is advertised as covering personalized doctor-prescribed protocols, unlimited doctor messaging, ongoing check-ins and adjustments, nutrition and lifestyle support, and express cold shipping. Medication is billed separately. One material tension deserves a direct answer before checkout: the commercial page says there is “nothing bolted on top,” but the terms permit a nominal, uniform technology transaction fee for each electronic prescription transmission, regardless of pharmacy choice. Its amount and application are not specified.
Ask for an itemized checkout showing the immediate medication charge, membership trial end date, first annual collection date and any transaction fee. Also ask whether supplies, auxiliary medicines or later laboratory work could cost extra; the consulted documentation does not resolve those items. Our questions beyond the monthly price can help organize that request. The published monthly amounts should remain visible in the comparison, but they are not the whole payment arrangement.
| Item | Documented position | Question before paying |
|---|---|---|
| Compounded semaglutide | $59/month; advertised same price at any dose | What formulation, route, presentation and quantity does this cover? |
| Compounded tirzepatide | $69/month; advertised same price at any dose | What exactly will the pharmacy dispense? |
| Membership | $199 annually, separate from medication | When does my trial end and the annual charge occur? |
| Prescription transmission | Terms permit a technology transaction fee; no amount stated | Will it apply to this order, and how much is it? |
| Other services or supplies | Some possible additional costs are not clarified | Are supplies, auxiliary medicines or later tests separate? |
How do the trial, cancellation and refund promises fit together?
Collective’s commercial page offers 21 days without a membership charge, during which the patient still pays for medication. It says cancellation before those 21 days end avoids the annual membership charge. The terms are narrower: new users “may be eligible” for a limited 21-day trial providing access to certain platform features as described at signup. Confirm eligibility and the exact deadline in the actual enrollment flow rather than treating the general advertisement as an unconditional free trial of treatment.
Purchased membership continues until canceled and renews automatically each year unless canceled online before the current membership period ends. Collective advertises account-based cancellation without phone calls. Under the terms, a canceled account stays active through the paid billing period, but membership fees and partial periods generally are not refundable except where law requires or purchase terms expressly provide otherwise. Cancellation stops a future renewal; it does not automatically reverse an annual fee already collected.
A separate commercial promise says patients receive a full refund if the doctor determines treatment is inappropriate and are not charged for medication they do not receive. Meanwhile, general terms call products and services nonreturnable and nonrefundable unless CollectiveOS decides otherwise. Ask which charges the clinical-decline refund covers and how it is requested. Also retain the checkout terms: despite price-lock marketing, the membership terms allow advance-notified price changes effective at the next membership period.
Can I use the service, and what does the initial review establish?
Collective advertises service in 44 states, with Alabama, California, Louisiana, Massachusetts, Mississippi and Washington listed as unavailable. The terms limit access to users located in supported U.S. states and exclude users outside the United States. Confirm availability for where you will actually be during care, not just a mailing address. The documentation does not provide complete clinical approval criteria, so geographic availability alone does not establish that someone will qualify for a prescription.
Enrollment begins with an online health assessment covering medical history, goals and previous GLP-1 experience. Collective says no in-person visit or laboratory work is needed to begin, and a U.S.-licensed doctor usually reviews the information within one or two days. That describes the start, not a promise that testing can never be requested. The terms require a consultation, a provider’s determination that the product is appropriate, and an issued prescription before a prescription product can be obtained.
The age language is internally inconsistent. Terms require users to represent they are at least 18, but also discuss parental or guardian permission for younger users; the privacy policy says the platform is not intended for under-18s and prohibits them from providing personal information. These documents do not establish a clear pediatric treatment pathway. For adults, a useful consultation agenda includes current medicines, supplements, allergies and pregnancy plans, topics NIDDK recommends discussing with the treating clinician.
What exactly would the pharmacy dispense?
Collective advertises compounded semaglutide and compounded tirzepatide, but the consulted documentation does not specify their administration route, presentation, added ingredients or shipment quantity. Those omissions prevent a precise product-level comparison. Ask for the proposed prescription’s full formulation and the dispensing pharmacy’s identity before accepting the offer. The medication-identification questions are especially relevant here: a familiar ingredient name does not answer what is in the actual preparation or how it is supplied.
The company says every prescription is written by a U.S.-licensed doctor, filled by a state-licensed U.S. pharmacy, and drawn from batches third-party tested for purity and potency. These are provider statements, not independently verified findings in this review. The consulted pages do not name the dispensing pharmacies or provide batch certificates or independent licensing documentation. Request the pharmacy name and relevant testing documentation, while recognizing that a dispensing pharmacy is not necessarily the entity that compounded the preparation.
FDA states that compounded preparations are not FDA approved and do not undergo its premarket review for safety, effectiveness and quality. That status alone does not prove clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Ask the prescriber why the proposed compounded preparation fits your needs; Collective’s commercial claims do not themselves establish that clinical rationale.
How do pharmacy choice and delivery work in practice?
Collective’s terms say a patient with an appropriate prescription may fill it at a pharmacy of their choice, as prompted during use of the services. That is useful flexibility, but the documentation does not establish that another pharmacy will honor Collective’s advertised medication price or included shipping arrangement. Ask how an outside-pharmacy prescription is transmitted, who collects payment, and whether the possible transmission fee applies. Pharmacy choice should not be mistaken for a portable guarantee of the advertised package.
After approval, Collective advertises cold-shipped, two-day express delivery to the patient’s door, with express cold shipping included in membership. The initial clinical review and shipping are separate stages. Neither establishes a total application-to-arrival deadline, and the documentation does not set out order preparation time, carrier details, lost-package replacement or temperature-incident procedures. Before ordering, get the pharmacy contact and ask who can resolve a delayed or damaged shipment without sending you between organizations.
For an injectable GLP-1 product that arrives warm or inadequately refrigerated, FDA explicitly advises not using it and contacting the provider or dispensing pharmacy. That guidance is conditional; Collective’s public pages do not establish the route of its advertised preparations. Ask what packaging and delivery checks apply to your actual product. Our delivery-problem questions can help prepare a practical handoff plan before a package arrives, rather than after something goes wrong.
Who answers questions after the first prescription?
Collective advertises unlimited doctor messaging, quarterly check-ins, ongoing adjustments, live group question-and-answer sessions with registered dietitians, and practical nutrition and lifestyle resources. These are meaningful service descriptions, but they do not specify messaging hours, response targets or the frequency of dietitian sessions. Ask whether the same clinician follows the case and how a concern gets escalated. “Unlimited” describes access to messages; it does not establish immediate replies or round-the-clock clinical coverage.
For people already using a GLP-1, Collective advertises transition support and the possibility of keeping the current dose if its doctor approves. Switching between its treatments also requires medical approval. Neither offer guarantees continuation of a prior prescription or acceptance of a requested treatment. Ask what records the new practice needs and how it coordinates the transition. NIDDK emphasizes that follow-up concerns tolerability and response, not merely whether another payment or refill is due.
The terms explicitly exclude emergencies and urgent situations and recommend maintaining a local primary care relationship because the platform’s services are not a substitute. The privacy policy also publishes questions@collective.org and (832) 280-7898 in its messaging-help language. Those are documented contact paths, not evidence of emergency clinical availability. Confirm separate routes for routine platform support, prescription questions and clinical concerns, along with business hours and expected response times; Spanish-language services are not confirmed.
What should I verify before deciding the offer fits?
Collective says it does not bill health insurance. It also says medication and membership may qualify for HSA/FSA reimbursement, with the plan administrator deciding what is reimbursable. Those are different issues: an advertised possibility of reimbursement is not an approval from your account administrator. Ask what receipts or supporting documents Collective can provide, then verify requirements with the administrator before relying on reimbursement as part of the purchase decision.
The site’s competitor-price comparison includes medication and membership, excludes promotions and prepayment discounts, and identifies competitor information as dating to August 2026. That comparison is a commercial snapshot, not a substitute for current checkout terms elsewhere. For Collective itself, the most useful comparison remains concrete: the exact preparation, monthly medication payment, annual membership, potential transmission fee, support access and refund boundaries. Avoid treating the low medication headline as a complete measure of the service.
The final questions should concern unresolved details rather than another general reassurance: Which medical practice accepts responsibility? Which pharmacy dispenses what formulation? What is collected today? What happens after a clinical decline, delivery problem or cancellation? Collective documents enough to make those questions specific, but not enough to answer all of them. Written responses would make the decision more informed without requiring a promise of individual results or an assumption that its compounded products reproduce outcomes from other products’ studies.
Questions & answers
Is Collective itself my medical provider?
No. Its terms describe CollectiveOS as a technology and membership platform, not a medical provider or group. Independent practices and clinicians control care, and independent pharmacies dispense prescriptions. Ask for the particular medical practice and pharmacy assigned to you; the privacy policy’s reference to MDIntegrations does not identify every patient’s treating organization.
Does the $59 or $69 price include membership?
No. Those are the advertised monthly medication prices for compounded semaglutide and compounded tirzepatide, respectively. The annual membership is separately priced at $199 after any applicable trial. The terms also allow a prescription-transmission technology fee without specifying its amount, so request the complete itemized charge before authorizing payment.
Are the first 21 days completely free?
No. The commercial offer waives the membership charge during that window, not medication payment. It says to cancel before the window ends to avoid the annual fee. The terms further qualify the trial as something new users may be eligible for, covering certain platform features. Confirm your specific eligibility and billing date during signup.
Can I cancel online and get my annual fee back?
Online cancellation is documented, but a refund generally is not. The terms keep the account active until the paid period ends and generally exclude membership and partial-period refunds, subject to stated exceptions. The advertised full refund following a doctor’s determination that treatment is inappropriate is a separate promise whose covered charges should be clarified.
Will I receive medication two days after signing up?
The documentation does not promise that. Collective describes physician review usually taking one or two days and, separately, two-day express cold shipping after approval. It does not establish the complete application-to-arrival timeline or order preparation interval. Ask when dispatch is expected and who handles delivery problems before relying on a particular arrival date.
Can I move an existing GLP-1 prescription to Collective?
Collective advertises supported transitions and says keeping a current dose is possible if its doctor approves. That is not guaranteed continuation. Its terms still require consultation, a clinical appropriateness decision and a prescription. Ask what prior records are needed, what preparation would be prescribed, and how the transition would be coordinated before assuming the offer matches your existing treatment.
Our assessment
Collective’s documentation offers several useful specifics: explicit medication prices, a separately identified annual membership, no required multi-month orders, online cancellation and a described follow-up package. Its limitations are equally decision-relevant. The actual formulation and dispensing pharmacy are not identified, a possible technology fee complicates the no-added-cost message, and trial and refund language needs reconciliation at checkout. The strongest next step is to request a written, itemized offer identifying the clinical practice, pharmacy, preparation, first charges, renewal date and problem-resolution contacts. Collective is documented as a route to GLP-1 prescribing through independent providers, not as the medical practice itself. Whether that arrangement fits depends on the answers to those practical questions, not the medication headline alone.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Wilding et al. (2021): STEP 1 semaglutide trial ↗
- Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
- Collective / CollectiveOS — legal/privacy ↗
- Collective / CollectiveOS — legal/terms of use ↗
- Collective / CollectiveOS — official website ↗